Govt Steps in to Expedite Approval for Covaxin as the Indigenous Vaccine

As the US and Europe will reopen soon, the government is trying to ensure that those vaccinated with Covaxin, particularly students are not denied entry by the countries.

India’s indigenous Covid vaccine Covaxin may have proven adequate efficacy but its endorsement from the WHO remains a cause of concern for the government. The concern for the vaccine aggravates as only a handful of countries have confirmed they will allow entry of those vaccinated by Covaxin.

Foreign Secretary Harsh Shringla will hold a meeting on Monday with Bharat Biotech, the company manufacturing Covaxin, to expedite the process of WHO approval for the indigenous vaccine in India, a Times of India report said.

Covaxin report is pending at the WHO and the government will work with Bharat Biotech to expedite the process, sources reportedly said.

As the US and Europe will reopen soon, the government is trying to ensure that those vaccinated with Covaxin, particularly students are not denied entry by the countries.

Scroll to Top